XOMAP.PFD (XOMA Royalty) Total Liabilities : $139.36 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is XOMA Royalty Total Liabilities?

XOMA Royalty's Total Liabilities for the quarter that ended in Dec. 2024 was $139.36 Mil.

XOMA Royalty's quarterly Total Liabilities declined from Jun. 2024 ($143.29 Mil) to Sep. 2024 ($138.53 Mil) but then increased from Sep. 2024 ($138.53 Mil) to Dec. 2024 ($139.36 Mil).

XOMA Royalty's annual Total Liabilities increased from Dec. 2022 ($16.37 Mil) to Dec. 2023 ($145.58 Mil) but then declined from Dec. 2023 ($145.58 Mil) to Dec. 2024 ($139.36 Mil).

XOMA Royalty Total Liabilities Historical Data

The historical data trend for XOMA Royalty's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XOMA Royalty Total Liabilities Chart

XOMA Royalty Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

38.86

24.69

16.37

145.58

139.36

XOMA Royalty Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															145.58	137.08	143.29	138.53	139.36

XOMA Royalty Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

XOMA Royalty's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	24.374	+	(107.358	+	3.214
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	4.41	+	0	+	0)
	=	139.36

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	221.277	-	81.921
	=	139.36

XOMA Royalty's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	24.374	+	(107.358	+	3.214
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	4.41	+	0	+	0)
	=	139.36

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	221.277	-	81.921
	=	139.36

XOMA Royalty Total Liabilities Related Terms

Thank you for viewing the detailed overview of XOMA Royalty's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

XOMA Royalty Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XOMA Royalty Corp (NAS:XOMAP.PFD) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

XOMAO.PFD:USA XOMA:USA 0M26:UK

Address

2200 Powell Street, Suite 310, Emeryville, CA, USA, 94608

Website

https://www.xoma.com

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.